1. Home
  2. BBIO vs TEO Comparison

BBIO vs TEO Comparison

Compare BBIO & TEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • TEO
  • Stock Information
  • Founded
  • BBIO 2015
  • TEO 1979
  • Country
  • BBIO United States
  • TEO Argentina
  • Employees
  • BBIO N/A
  • TEO N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • TEO Telecommunications Equipment
  • Sector
  • BBIO Health Care
  • TEO Telecommunications
  • Exchange
  • BBIO Nasdaq
  • TEO Nasdaq
  • Market Cap
  • BBIO 5.6B
  • TEO 5.9B
  • IPO Year
  • BBIO 2019
  • TEO N/A
  • Fundamental
  • Price
  • BBIO $36.85
  • TEO $11.64
  • Analyst Decision
  • BBIO Strong Buy
  • TEO Sell
  • Analyst Count
  • BBIO 12
  • TEO 1
  • Target Price
  • BBIO $52.27
  • TEO $6.10
  • AVG Volume (30 Days)
  • BBIO 2.7M
  • TEO 193.0K
  • Earning Date
  • BBIO 02-20-2025
  • TEO 11-07-2024
  • Dividend Yield
  • BBIO N/A
  • TEO 2.49%
  • EPS Growth
  • BBIO N/A
  • TEO N/A
  • EPS
  • BBIO N/A
  • TEO 0.21
  • Revenue
  • BBIO $221,902,000.00
  • TEO $1,780,106,477.00
  • Revenue This Year
  • BBIO $2,306.75
  • TEO $88.31
  • Revenue Next Year
  • BBIO N/A
  • TEO $16.92
  • P/E Ratio
  • BBIO N/A
  • TEO $13.47
  • Revenue Growth
  • BBIO 2285.27
  • TEO N/A
  • 52 Week Low
  • BBIO $21.62
  • TEO $5.52
  • 52 Week High
  • BBIO $39.47
  • TEO $15.54
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 63.77
  • TEO 46.40
  • Support Level
  • BBIO $35.36
  • TEO $10.50
  • Resistance Level
  • BBIO $39.47
  • TEO $11.32
  • Average True Range (ATR)
  • BBIO 1.93
  • TEO 0.71
  • MACD
  • BBIO 0.26
  • TEO 0.04
  • Stochastic Oscillator
  • BBIO 70.79
  • TEO 65.32

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About TEO Telecom Argentina SA

Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company provides services in Argentina (mobile, cable television, Internet and fixed and data services), Paraguay (mobile, Internet and satellite TV services), Uruguay (cable television services) and the United States (fixed wholesale services).

Share on Social Networks: